We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.1%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$22.8B
AUM Growth
+$2.31B
Cap. Flow
+$2.06B
Cap. Flow %
9.04%
Top 10 Hldgs %
14.6%
Holding
2,473
New
253
Increased
1,354
Reduced
677
Closed
147

Sector Composition

Rank Sector Weight
1 Healthcare 9.41%
2 Technology 8.67%
3 Financials 7.91%
4 Industrials 7.66%
5 Energy 7.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JNK icon
76
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$6.92B
$60.3M 0.26%
512,345
+100,790
+24% +$11.8M
GIS icon
77
General Mills
GIS
$19.7B
$60.1M 0.26%
1,061,004
+68,254
+7% +$3.64M
FLRN icon
78
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
$3.09B
$59.5M 0.26%
1,947,217
+314,191
+19% +$9.59M
CVS icon
79
CVS Health
CVS
$122B
$58.8M 0.26%
569,651
+23,344
+4% +$2.36M
ABT icon
80
Abbott
ABT
$187B
$58.8M 0.26%
1,268,907
+84,310
+7% +$3.87M
IRM icon
81
Iron Mountain
IRM
$36.1B
$58.7M 0.26%
1,609,277
+459,953
+40% +$17.8M
LMT icon
82
Lockheed Martin
LMT
$136B
$58.3M 0.26%
287,159
+34,224
+14% +$6.76M
BMY icon
83
Bristol-Myers Squibb
BMY
$132B
$55.9M 0.25%
865,962
+49,210
+6% +$3.08M
RDS.B
84
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$55M 0.24%
876,896
+105,492
+14% +$6.97M
SYY icon
85
Sysco
SYY
$40.3B
$54.7M 0.24%
1,448,611
+73,291
+5% +$2.89M
NVS icon
86
Novartis
NVS
$297B
$54.6M 0.24%
618,472
+75,300
+14% +$6.68M
TYC
87
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
$53.7M 0.24%
1,190,952
+111,815
+10% +$4.98M
CME icon
88
CME Group
CME
$94.8B
$53.4M 0.23%
564,092
-107,607
-16% -$9.97M
RGC
89
DELISTED
Regal Entertainment Group
RGC
$53.2M 0.23%
2,330,879
+214,311
+10% +$4.75M
ABBV icon
90
AbbVie
ABBV
$435B
$52.3M 0.23%
894,196
+97,243
+12% +$5.87M
WMT icon
91
Walmart Inc
WMT
$890B
$51.6M 0.23%
1,883,103
+158,013
+9% +$4.48M
MDT icon
92
Medtronic
MDT
$112B
$49.1M 0.22%
629,739
+360,335
+134% +$27.3M
D icon
93
Dominion Energy
D
$59.3B
$48.9M 0.21%
690,425
-86,585
-11% -$6.42M
F icon
94
Ford
F
$55.7B
$47.8M 0.21%
2,958,786
+783,042
+36% +$12.4M
SCZ icon
95
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.7B
$47.1M 0.21%
951,395
-137,778
-13% -$6.66M
APC
96
DELISTED
Anadarko Petroleum
APC
$46.9M 0.21%
566,410
+89,278
+19% +$7.31M
ADP icon
97
Automatic Data Processing
ADP
$108B
$46.4M 0.2%
541,363
+72,289
+15% +$6.23M
AMAT icon
98
Applied Materials
AMAT
$428B
$45.8M 0.2%
2,032,192
+51,566
+3% +$1.24M
TGT icon
99
Target
TGT
$68B
$45.8M 0.2%
557,513
-41,386
-7% -$3.2M
TEL icon
100
TE Connectivity
TEL
$62.6B
$45.1M 0.2%
629,885
+95,101
+18% +$6.53M

Similar funds

Raymond James & Associates's Q1 2015 Portfolio in Review

As of Q1 2015, Raymond James & Associates held 2,473 positions worth $22.8B, up 11% from $20.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Raymond James & Associates deployed $2.06B of net new capital in Q1 2015, opening 253 new positions and adding to 1,354 existing holdings. Its largest new stake was Hormel Foods: 461,564 shares worth $13.1M.

By sector, the portfolio is most concentrated in Healthcare at 9.4% of assets, up from 8.7% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was NYLI Hedge Multi-Strategy Tracker ETF, an estimated $59.4M trimmed.

  • Raymond James & Associates's largest Q1 2015 buy was Hormel Foods: 461,564 shares worth $13.1M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q1 2015, an estimated $83.8M increase.
  • Raymond James & Associates's biggest Q1 2015 reduction was NYLI Hedge Multi-Strategy Tracker ETF, cutting an estimated $59.4M.
  • Raymond James & Associates fully exited Edgewell Personal Care in Q1 2015, selling an estimated $21.8M.
  • Raymond James & Associates's ten largest holdings make up 15% of its $22.8B portfolio in Q1 2015.
  • Raymond James & Associates opened 253 new positions and closed 147 in Q1 2015.
  • Raymond James & Associates's portfolio value rose 11% quarter-over-quarter to $22.8B.

Based on Raymond James & Associates's 13F filing for Q1 2015, filed 28 Apr 2015.